Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00442013 · ClinicalTrials.gov registry record · Phase 4
Lansoprazole to Treat Children With Asthma
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 306
- Enrollment target
NCT00442013: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT00442013 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 306 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00442013, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 306 participants
- Enrollment target
Study Summary
Many individuals with asthma also experience gastroesophageal reflux disease (GERD), a condition in which excess stomach acid flows backwards into the esophagus. This study will evaluate the effectiveness of lansoprazole, a medication commonly used to treat GERD in improving asthma control and reducing symptoms in children with poorly controlled asthma.
Primary Outcome
Score ranges from 0 to 6, a lower score indicated better asthma control. Scores above 1.5 are indicative of poor asthma control; score obtained from questionnaire with 6 questions related to asthma control and FEV (amount of air expired in the first second during a forced expiratory maneuver); number presents an average of the change from baseline to all follow-up points
Interventions
- DRUG Matching placebo
- DRUG Lansoprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
What the finished NCT00442013 record still lists
NCT00442013 is an interventional study that assigns participants to a tested intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (41% lower).
The record links to 0 conditions, and to 2 interventions - of which Matching placebo is the first listed.
NCT00442013 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00442013 about?
NCT00442013 is a clinical study titled "Lansoprazole to Treat Children With Asthma". Many individuals with asthma also experience gastroesophageal reflux disease (GERD), a condition in which excess stomach acid flows backwards into the esophagus. This study will evaluate the effectiveness of lansoprazole, a medication commonly used to treat GERD in improving asthma control and reduc...
What is the current status of trial NCT00442013?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 306 participants. The study started on 2007-03. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00442013?
The interventions under investigation include: Matching placebo (DRUG), Lansoprazole (DRUG).
Who is sponsoring clinical trial NCT00442013?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00442013's enrollment target sits among peer trials
306 264th of 2000 higher than 1,737 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia